You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
普門科技(688389.SH):公司糖化血紅蛋白業務在國際市場的增長速度高於國內
格隆匯 08-07 07:50

格隆匯8月7日丨普門科技(688389.SH)近期在接待機構投資者調研時表示,公司糖化血紅蛋白業務在國際市場的增長速度高於國內。糖化業務全球範圍主要競爭對手來自於國際知名IVD品牌。高壓液相色譜法是檢測糖化血紅蛋白的金標準方法學,公司的糖化血紅蛋白分析儀採用高壓液相色譜法,可實現1分鐘內分離和提示血紅蛋白變異體,無需切換試劑或檢測模式。得益於公司國際渠道的合理佈局以及公司糖化產品的核心競爭力,據海關出口數據,目前公司在該領域已經是國內出口第一品牌。在國內市場,糖化業務的重點推廣方向之一是進口品牌替代,通過發展更多的全國各地代理商,利用公司高中低全系列多型號糖化產品,進入更多國內三級醫院和各級醫療機構。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account